For Immediate Release
Chicago, IL – November 25, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include General Motors Company GM, Delta Apparel, Inc. DLA, Highpoint Resources Corp. HPR, Deere & Company DE and Capital Bancorp, Inc. CBNK.
Here are highlights from Tuesday’s Analyst Blog:
Cyclical Stocks Pop on Vaccine Progress: 5 Solid Buys
A relentless rise in coronavirus cases across the United States has raised concerns that the government may yet again impose lockdowns, which again will hamper economic growth and corporate profits.
In fact, on Nov 22, Nevada became the latest state to impose shutdown measures to curb the spread of the virus. The state applied curbs on eateries, pubs and casinos along with imposing strict laws to ensure the covering of faces for a short period of time.
Further, expectations of further stimulus measures to rejuvenate the economy were dampened after some of the Fed’s pandemic-led emergency aid programs were terminated by Treasury Secretary Steven Mnuchin last week.
But, on Nov 23, optimistic news on the coronavirus vaccine front gave a new lease of life to the U.S. economy. And with fears of an economic downturn ebbing, the fate of cyclical stocks brightened. Cyclical stocks or discretionary companies moved north yesterday as consumers are now widely expected to purchase products on signs of an improving economy.
Notably, cyclical stocks including vehicle manufacturers, apparel goods producers, airliners and hotels rallied on expectations of sales improvement once the economy starts to recover.
At the same time, energy, industrial and financial shares are cyclical in nature and witnessed a jump in share prices yesterday. Particularly, energy shares scaled north as a potential breakthrough in the coronavirus vaccine space will ease concerns about the virus, and a greater number of people will take to the skies again, resulting in an uptick in demand for fuel oil.
Buoyed by the positivity, the Energy Select Sector SPDR, the Industrials Select Sector SPDR, the Financials Select Sector SPDR and the Consumer Discretionary Select Sector SPDR rose 7.1%, 1.7%, 1.9% and 1.1%, respectively, on Nov 23.
But which vaccine news is driving cyclical stocks? An interim analysis showed that the vaccine candidate developed by AstraZeneca in collaboration with the University of Oxford had an average efficacy of 70%, easily surpassing the regulatory authority’s approval threshold of a minimum 50% efficacy. It’s worth pointing out that one dosing regimen in fact demonstrated 90% effectiveness, while another had a 62% efficacy.
In the race to the coronavirus vaccine, AstraZeneca has now joined Pfizer and Moderna. Late-stage preliminary analysis data from Pfizer and Moderna showed that their vaccine candidates were almost 95% effective. Both Pfizer and Moderna vaccine candidates, by the way, used mRNA technology that uses genetic materials to boost the immune system in a body (read more: 3 Stocks to Win Big as Race for Coronavirus Vaccine Heats Up).
5 Top Cyclical Stocks to Invest In Right Away
Economically-sensitive cyclical stocks are not only surging now but are also likely to scale northward in the near term on positive coronavirus vaccine developments. Hence, it won’t be a bad proposition to invest in a few right now. Here are five such stocks that flaunt a Zacks Rank #1 (Strong Buy) or 2 (Buy).
General Motors Company is one of the world’s largest automakers, leading the U.S. market share with around 17% of the industry’s total sales in 2019. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has risen 83.2% over the past 60 days. The company’s expected earnings growth rate for the current quarter is more than 100%.
Delta Apparel, Inc. is a vertical manufacturer of knitwear products for the entire family. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has moved 39.8% up over the past 60 days. The company’s expected earnings growth rate for the next year is 18.1%.
Highpoint Resources Corp. is an exploration and production company. It focuses on the development of oil and natural gas assets, primarily in the Denver-Julesburg Basin of Colorado. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has climbed 17.2% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 208.8% and 295.3%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.
Deere & Company manufactures and distributes various equipment worldwide. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has moved 3.6% up over the past 60 days. The company’s expected earnings growth rate for the next year is 39.3%.
Capital Bancorp, Inc. is a commercial-focused national banking association, which offers commercial and consumer banking services. The company currently has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved up 59.6% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 66.7% and 119.1%, respectively.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Join us on Facbook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Deere & Company (DE): Free Stock Analysis Report
General Motors Company (GM): Free Stock Analysis Report
Capital Bancorp, Inc. (CBNK): Free Stock Analysis Report
Delta Apparel, Inc. (DLA): Free Stock Analysis Report
HIGHPOINT RESOURCES CORP (HPR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.